Reports > Life Sciences > Autoimmune Disease Diagnostics Market Report
Autoimmune Disease Diagnostics Market Size, Share, Industry Trends and Forecast to 2033
This report provides an in-depth analysis of the Autoimmune Disease Diagnostics market, emphasizing market trends, growth forecasts, and competitive dynamics from 2023 to 2033.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $8.70 Billion |
| CAGR (2023-2033) | 7.2% |
| 2033 Market Size | $17.78 Billion |
| Top Companies | Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Roche Diagnostics, Becton, Dickinson and Company (BD) |
| Last Modified Date | 15 Nov 2024 |
Autoimmune Disease Diagnostics Market Report (2023 - 2033)
Autoimmune Disease Diagnostics Market Overview
What is the Market Size & CAGR of Autoimmune Disease Diagnostics market in 2023?
Autoimmune Disease Diagnostics Industry Analysis
Autoimmune Disease Diagnostics Market Segmentation and Scope
Request a custom research report for industry.
Autoimmune Disease Diagnostics Market Analysis Report by Region
Europe Autoimmune Disease Diagnostics Market Report:
In Europe, the market size is projected to rise from USD 2.56 billion in 2023 to USD 5.24 billion in 2033. The increasing incidence of chronic diseases and a robust regulatory environment supporting innovation contribute to growth.Asia Pacific Autoimmune Disease Diagnostics Market Report:
In 2023, the market in the Asia Pacific region is valued at USD 1.60 billion and is expected to grow to USD 3.27 billion by 2033. Factors like increased prevalence of autoimmune diseases, improvements in healthcare infrastructure, and growing awareness are driving this growth.North America Autoimmune Disease Diagnostics Market Report:
North America dominates the market, with a value of USD 3.38 billion in 2023, anticipated to rise to USD 6.91 billion by 2033. High healthcare expenditure, advanced technology adoption, and a well-established diagnostic infrastructure are key drivers.South America Autoimmune Disease Diagnostics Market Report:
The South American market, valued at USD 0.18 billion in 2023, is forecasted to reach USD 0.38 billion by 2033. The growth is attributed to expanding access to healthcare and increased investments in medical technology.Middle East & Africa Autoimmune Disease Diagnostics Market Report:
The Middle East and Africa market, valued at USD 0.98 billion in 2023, is expected to reach USD 2.00 billion by 2033. The growth is supported by improving healthcare access and the rising burden of autoimmune diseases in the region.Request a custom research report for industry.
Autoimmune Disease Diagnostics Market Analysis By Test Type
Global Autoimmune Disease Diagnostics Market, By Test Type Market Analysis (2023 - 2033)
The Autoimmune Disease Diagnostics market by test type is dominated by laboratory tests, with a market size of USD 5.49 billion in 2023, projected to increase to USD 11.22 billion by 2033, accounting for 63.07% share. Other significant segments include molecular diagnostics valued at USD 2.46 billion and imaging techniques at USD 0.76 billion in 2023, growing accordingly to USD 5.02 billion and USD 1.55 billion by 2033.
Autoimmune Disease Diagnostics Market Analysis By Automation Level
Global Autoimmune Disease Diagnostics Market, By Level of Automation Market Analysis (2023 - 2033)
Market segmentation by level of automation shows significant demand for fully automated diagnostics, projected to grow from USD 0.76 billion in 2023 to USD 1.55 billion by 2033, representing an 8.7% market share. Semi-automated diagnostics also see growth, valuing USD 2.46 billion in 2023 and expected to reach USD 5.02 billion by 2033.
Autoimmune Disease Diagnostics Market Analysis By End Users
Global Autoimmune Disease Diagnostics Market, By End Users Market Analysis (2023 - 2033)
Hospitals remain the leading end-user segment for Autoimmune Disease Diagnostics with a market valuation of USD 4.51 billion in 2023, expected to grow to USD 9.22 billion by 2033, capturing 51.82% of the market share. Clinical laboratories and research institutions also form significant portions of the market, reflecting ongoing diagnostic innovation and testing needs.
Autoimmune Disease Diagnostics Market Analysis By Technology
Global Autoimmune Disease Diagnostics Market, By Technology Market Analysis (2023 - 2033)
In terms of technology, traditional diagnostic techniques comprising manual diagnostics account for USD 5.49 billion in 2023, projected to remain stable at a 63.07% market share. Advanced diagnostic techniques are expected to gain traction, increasing from USD 2.46 billion in 2023 to USD 5.02 billion by 2033.
Autoimmune Disease Diagnostics Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Autoimmune Disease Diagnostics Industry
Abbott Laboratories:
Abbott is a global healthcare company focusing on diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. They are at the forefront of innovation in autoimmune diagnostics.Thermo Fisher Scientific:
Thermo Fisher Scientific provides analytical instruments, reagents, and consumables for diagnostics and research. They actively develop solutions for autoimmune disease testing.Siemens Healthineers:
Siemens Healthineers specializes in imaging and diagnostic devices and solutions that significantly improve the efficiency of autoimmune disease diagnostics.Roche Diagnostics:
Roche is a leading player in the healthcare sector, focusing on innovative diagnostics solutions and tests that address various autoimmune diseases.Becton, Dickinson and Company (BD):
BD is known for its contributions to medical devices and diagnostics, focusing on enhancing the accuracy and speed of autoimmune disease diagnostics.We're grateful to work with incredible clients.
